In the heart of North Carolina, Research Triangle Park (RTP) stands as a leading hub for innovation in biotechnology. As companies strive to bring therapies from concept to reality, partnering with a Contract Research Organization (CRO) specializing in preclinical services becomes essential. At InfinixBio, we offer robust preclinical services tailored to meet the unique needs of biotech and pharmaceutical companies, ensuring a streamlined pathway from early discovery through to IND-enabling studies.
Preclinical services encompass a range of activities aimed at evaluating the safety and efficacy of drug candidates before they enter clinical trials. These services often include:
At InfinixBio, we understand the intricacies involved in preclinical research and provide comprehensive solutions that foster successful outcomes in drug development.
Our interdisciplinary team consists of highly qualified professionals, including a significant number of PhDs, bringing extensive experience in scientific research and development. With over 60 issued and pending patents, we leverage our collective expertise to address the challenges of drug development comprehensively.
From oncology to cardiovascular research, InfinixBio specializes in providing preclinical services across various therapeutic areas. Our customizable solutions ensure that each project receives the focused attention it deserves, aligning with the specific goals and milestones of our clients.
Emphasizing the application of advanced technologies, we utilize innovative methodologies such as bioanalytical method development and validation. This approach enhances the accuracy and reliability of our results, ultimately fostering informed decision-making for our clients.
With expertise in assay development, we help clients establish robust testing methods to accurately measure biological responses to drug candidates.
Understanding the absorption, distribution, metabolism, and excretion (ADME) properties of drug candidates is crucial. Our pharmacokinetic analysis provides insights vital for dose selection and efficacy evaluation.
Selecting appropriate animal models is critical for preclinical testing. Our scientists excel in creating tailored models that mimic human disease conditions, laying the groundwork for successful clinical trials.
Preparing for Investigational New Drug (IND) submission requires meticulous study designs. InfinixBio guides clients through this pivotal stage, ensuring all necessary preclinical data is robust and comprehensive.
What are the main objectives of preclinical research?
Main objectives include assessing safety, understanding drug mechanisms, and establishing effective dosages before advancing to clinical trials.
How does InfinixBio ensure compliance with regulatory standards?
We adhere to Good Laboratory Practices (GLP) and maintain a comprehensive understanding of relevant regulatory requirements, facilitating smoother submissions and compliance checks.
What types of animal models does InfinixBio utilize?
We employ a variety of animal models tailored to the disease conditions being studied, optimizing preclinical testing results.
As the biotech and pharmaceutical ecosystem in Research Triangle Park continues to thrive, the need for reliable preclinical services is more critical than ever. At InfinixBio, our commitment to scientific excellence and innovation positions us as your preferred partner for drug development.
Ready to enhance your preclinical research capabilities? Contact us today to learn more about how InfinixBio can support your project and help bring your discoveries to market.
Our experienced lab team is here to help. Reach out today to learn more.
Back to Glossary